Cellectis: Showcasing Encouraging Data, But Still Early To Make A Run Like This
Source: SeekingAlpha
2025-12-18 08:52:35 ET
Topline Summary and Update
Read the full article on Seeking Alpha
For further details see:
Cellectis: Showcasing Encouraging Data, But Still Early To Make A Run Like This
Cellectis S.A.
NASDAQ: CLLS
CLLS Trading
1.27% G/L:
$3.98 Last:
4,091 Volume:
$3.97 Open:
CLLS Latest News
December 15, 2025 05:39:45 pm
Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis
December 08, 2025 01:30:00 am
ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL
CLLS Stock Data
$283,328,921
39,774,190
N/A
15
N/A
Biotechnology & Life Sciences
Healthcare
FR
Paris
